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Transcription factors (TFs), such as Snail, Slug and Twist, control the down-regulation of cell–cell adhesion molecule E-
cadherin in ovarian cancer. Low E-cadherin aids tumour cells in undergoing epithelial–mesenchymal transition (EMT) to
motile morphology, disseminating to other organs. High TF levels have also correlated with chemoresistance and poor prog-
nosis. This review aims to discern mechanisms of E-cadherin reduction by TFs and identiﬁes hypoxia-inducible factor 1α
(HIF1α) as an upstream regulator in hypoxic conditions. Association with chemoresistance is investigated, and whether its
reversal is possible. Snail was found to bind more strongly to the E-cadherin promoter than Slug; it was suggested that Snail
maintained EMT whilst Slug induced it. The use of differential zinc ﬁngers by Snail and Slug to bind to the E-cadherin pro-
moter supported this. HIF1α was shown to lie upstream of all three TFs and protein degradation or post-transcriptional regu-
lation using miR-548c may regulate of Twist downstream. Further study into this is needed. High Snail expression correlated
with cisplatin resistance, with knockdown of Snail reversing it. The same may be true for Twist and Slug, though some studies
conﬂicted this. These ﬁndings show promising potential of TFs and HIF1α as therapeutic targets for EMT prevention and
even chemoresistance reversal.
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Introduction
Ovarian cancer is one of the largest causes of cancer death
among women (The American Cancer Society, 2017), with
the highest death rate of female reproductive cancers. It was
estimated that around 22 440 women in the US would be
newly diagnosed with ovarian cancer in 2017, with 14 080
deaths as a result. The disease is particularly lethal due to its
vague symptoms and thus, lack of early diagnosis. Though
there are many histological types of ovarian tumours, most
originate from the ovarian surface epithelium (OSE), and dis-
seminate through the lymphatic system or peritoneal ﬂuid,
reaching the omentum and peritoneum (Vergara et al., 2010).
This dissemination results in high malignancy ~90% from
OSE (Cho and Shih, 2009). For dissemination to occur, cells
must detach from the ovary and become motile, transitioning
from epithelial to mesenchymal, a ﬁbroblast-like morphology
(Vergara et al., 2016). This is epithelial–mesenchymal trans-
ition (EMT). It occurs through down-regulation of cell–cell
adhesion molecules—in particular E-cadherin. Several tran-
scription factors controlling this expression have been identi-
ﬁed—Snail, Slug, Twist1/2, Zeb1/2 and Sip1 (Vergara et al.,
2016). Snail and Slug are zinc-ﬁnger proteins involved in
changing cell shape and morphology in migratory cells
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(Dattoli et al., 2015). Twist is a basic helix-loop-helix
involved in embryonic development and cellular differenti-
ation (Nuti et al., 2014). All three bind to E-boxes in the E-
cadherin promoter and have been associated with its down-
regulation and resulting EMT (Vergara et al., 2016).
Furthermore, these transcription factors have been associated
with chemoresistance (Kurrey et al., 2009; Nuti et al., 2014).
A few upstream regulators of Snail, Slug and Twist, for
instance hypoxia-inducible factor 1α (HIF1α), have been
identiﬁed (Thiery et al., 2009). These are potential therapeutic
targets for the repression of transcription factors and subse-
quent reversal of chemoresistance, but the mechanisms
through which these transcription factors act must ﬁrst be
understood. This review will focus on the mechanisms of
Snail, Slug and Twist in down-regulation of E-cadherin and
differences between them. Focus will be placed on HIF1α as
an upstream regulator of these factors. Their association with
cisplatin resistance will also be investigated. Cisplatin is a
standard chemotherapeutic agent, commonly used to treat
ovarian carcinoma (The American Cancer Society, 2017).
Resistance of the tumour to cisplatin is a major hindrance to
the effectiveness of treatment (Miow et al., 2014). Should
Snail, Slug or Twist be associated with this resistance, their
inhibition might aid in cisplatin resistance reversal.
Differences between Snail and Slug
transcription factors
Snail and Slug have been shown to correlate with reduced level
of E-cadherin expression (Batlle et al., 2000; Bolós et al.,
2003). However, there is evidence that the two act in differen-
tial ways. Immunoblotting of SKOV3 OSE carcinoma cell lines
(Kurrey et al., 2005) showing ectopic expression of mSnail and
mSlug individually resulted in EMT. It was found that Snail
overexpression repressed E-cadherin, β-catenin, occludin and
Zo1—adherens and tight junction components. Interestingly,
Slug overexpression also resulted in the repression of desmo-
somal junction components. This is indicative of the two’s dif-
ferential roles in EMT induction. Correspondingly, mutation
of zinc ﬁngers of Snail and Slug in mice HEK293T and OSE
carcinoma cells (Villarejo et al., 2014) showed the use of differ-
ent zinc ﬁngers in repression of E-cadherin. Mutation of ZF1
and ZF2 simultaneously in Snail mice leads to complete the
loss of E-cadherin repression. Contrastingly, repression of ZF3
or ZF4 individually in Slug mice was required for the same
effect. This further supports the idea that the two act differently
on E-cadherin, using different zinc ﬁngers. It is plausible that
Snail is required to maintain EMT, whilst Slug aids in its induc-
tion. The study by Kurrey et al. (2005) using hypoxic condi-
tions showed initial increased Slug mRNA levels, which then
reduced to the basal level after 12 h. Snail, however, was only
detected after 60 h. This supports the theory that Snail stabi-
lises rather than induces EMT, being triggered at a later stage.
Indeed, Snail was found to have a stronger binding afﬁnity for
the E-cadherin promoter than Slug. Band shift studies of
MDCK (lung cancer) cells in another study (Bolós et al., 2003)
supported this. This indicates Snail’s ability to stably regulate
E-cadherin expression compared to Slug.
Though this evidence is fairly conclusive, it should be
remarked that reliability of the studies above is questionable.
Stable transfection of Snail and Slug into SKOV3 cells in the
study by Kurrey et al. (2005) was only successful in two and
one clones respectively. Without repeat stable samples to
check, E-cadherin repression could be concluded to be a result
of random mutation. Furthermore, a study by Bolós et al.
(2003) using pcDNA3-Slug and Snail transfection separately
into ovarian cancer cells showed the ability of Slug to induce
EMT independently of Snail. This contradicts the hypothesis
of Snail and Slug work synergistically in this process.
Nonetheless, this study uses MDCK cells rather than ovarian
cancer cells. Snail and Slug may interact differently in these
two tissues. Future studies are required, using ovarian cancer
cells and investigating E-cadherin levels over a longer time
period. It may have been that Snail expression would have
increased in MDCK cells, given time.
Interestingly, the study by Kurrey et al. (2005) showed
Slug upregulation as a result of hypoxia, suggesting the
involvement of HIF1α upstream. Hypoxia induced expression
of Snail, HIF1α and Slug. E-cadherin also decreased, most
likely as a result. It is possible, therefore, that Slug may induce
E-cadherin repression under adverse conditions such as hyp-
oxia. Snail may then act later to maintain EMT. HIF1α may
therefore be a target for therapeutic knockout. Studies should
be undergone to investigate the effect of this. It may be that in
the absence of sufﬁcient oxygen, HIF1α is released to cause
dissemination through Slug, Snail and Twist upregulation.
CRISPR/cas9 could be used to knockout HIF1α to test this
theory. The effect of differing oxygen levels on tumour dis-
semination might also be a valid area of study.
Twist repression of E-cadherin and
HIF1α involvement
More recently, Twist was identiﬁed as a transcriptional
repressor of E-cadherin. Examination of Twist and E-
cadherin expression in ovarian cancer tissues by PCR testing
(Wang et al., 2013) showed high Twist expression and low E-
cadherin compared to normal ovarian tissue. Use of RNAi to
knockout expression resulted in signiﬁcant increase in E-
cadherin, as well as β-catenin. This corroborates results found
by Kim et al. (2014) in a similar study using immunohisto-
chemistry to examine expression in 123 ovarian cancer cases.
Twist expression correlated to reduced E-cadherin expres-
sion, as well as overall survival. Both studies indicate the dir-
ect repression of E-cadherin by Twist and its further
association with poor prognosis.
Interestingly, the study by Kim et al. also showed increased
HIF1α expression corresponding to Twist. This relationship
was noted in other studies, perhaps indicating the role of a
HIF1α/TWIST/E-cadherin pathway in EMT. Microarray
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evaluation of expression in normal vs carcinoma endometrial
samples (Feng et al., 2013) showed a signiﬁcant (p < 0.01)
increase in HIF1α and Twist along with decreased E-
cadherin. HIF1α overexpression correlated with increased
Twist. This further supports the hypothesis that HIF1α lies
directly upstream of Twist. However, though signiﬁcant (p<
0.01), the correlation found using a Spearman’s rank test was
weak (r= 0.249). This suggests either a coincidental relation-
ship between the two, or that other factors may be required to
interact with HIF1α to induce Twist. This would explain why
upregulation of HIF1α resulted in increased Twist expression
in some, but not all cases. Furthermore, a larger sample size
of endometrial carcinoma patients than normal endometrial
samples was used. This might inﬂuence the rise in signiﬁcance
of the results. Further research is necessary to prove this
mechanism of E-cadherin repression, perhaps by using
CRISPR/Cas9 to knockout HIF1α.
Another explanation for the weak correlation between
HIF1α and Twist is the activity of post-transcriptional or trans-
lational repression. In one study (Yin et al., 2013), Twist was
transfected into epithelial ovarian cancer stem cells using plas-
mids containing the full-length gene. As expected, this resulted
in a signiﬁcant increase in Twist mRNA expression. However,
protein expression did not increase alongside. This implies the
involvement of factors repressing the protein after transcrip-
tion. This could occur through the use of microRNAs, or deg-
radation of the protein. The use of MG132 to block
proteasome activity restored expression of Twist protein along-
side its mRNA, suggesting regulation to be through protein
degradation. In contrast, the use of luciferase reporter assay by
Sun et al. (Sun et al., 2016) showed Twist to be a target of
miR-548c. miR-548c is a microRNA involved in translational
repression or degradation of RNA. This contests the former
study (Yin et al., 2013) and suggests that Twist is regulated
through the repression degradation of RNA rather than pro-
teasomal degradation. It is of note, however, that it is possible
for both mechanisms of Twist regulation to occur (Fig. 1).
Further study of upstream regulatory factors of Twist is
required, not only to prove or disprove these mechanisms, but
also to identify potential targets for treatment. If miR-548c
does indeed repress Twist, it has potential for future thera-
peutic treatment.
Negative regulation of Snail and
Slug transcription factors via Twist
Not only is Twist negatively regulated, but burgeoning evi-
dence suggests that it may regulate Snail and Slug expression.
In a study by Forghanifard et al. (2017) ectopic expression of
Twist via transfection into KYSE-30 cells drastically reduced
Snail expression, with a 7-fold reduction in Snail mRNA.
Furthermore, both TWIST and Snail are induced downstream
of nuclear factor kappa B (NF-κB)—a signalling pathway
heavily involved in inﬂammation (Šošic´ et al., 2003). This
upregulation appears to act as a negative feedback loop, with
Twist inhibiting further NF-κB activation. Whether Snail may
also aid in this negative regulation is yet to be uncovered. It
may be that, as well as inhibiting NF-κB, Twist mediates Snail
expression in EMT. Chip immunoprecipitation by Lander
et al. (2013) revealed binding of Snail and Slug to E-box
sequences via zinc-ﬁnger interaction with the Twist C-
terminal. Indeed, deletion of the C-terminal WR domain abol-
ished Twist association with Snail, as well its inhibition of
Slug chromatin recruitment. Furthermore, co-expression of
Snail with Twist stabilised the protein. This stabilisation was
hypothesised to occur via Snail interference with other Twist-
binding proteins (Lander et al., 2013). Interestingly, inhib-
ition of Twist phosphorylation by GSK-3β led to decreased
Twist/Slug interaction. These ﬁndings outline a complex, hier-
archical method of Snail, Slug and Twist regulation, with
each factor mediating the other. While Snail and Slug control
early stage EMT, Twist may act later to downregulate Snail
and Slug, thus regulating late stage EMT.
The discovery of GSK-3β interaction with Twist via phos-
phorylation adds further complexity. It is plausible that Twist
association with Snail and Slug is regulated by GSK-3β, ensur-
ing its occurrence only in late stage EMT. Despite the conceiv-
ability of this idea, it is notable that study into this interaction
by Lander et al. (2013) was performed in the context of
Xenopus neural crest development. Thus, extrapolation of
these ﬁndings to ovarian tumours is a stretch. It is advised,
therefore, that further studies of Twist, Snail and Slug inter-
action be performed speciﬁcally in OSE tissue. Nonetheless,
these studies present an intriguing model of EMT regulation
to be corroborated by study in other tissues.
Figure 1. Summary of HIF1α induced activation of Snail, Slug and
Twist and subsequent EMT. HIF1α binds DNA, resulting in TF
transcription.miR-548cmay bind and degrade Twist RNA. Proteasome
activity could also regulate Twist protein levels. Translated TFs bind
DNA inducing several expression alterations, including E-cadherin
repression. Evidence indicates Slug induces EMT whilst Snail binds
later to stabilise and maintain repression of adhesion molecules.
Repression of said molecules aids in transition to mesenchymal
morphology in EMT.
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Transcription factors and cisplatin
resistance
Evidence that EMT may be related to cisplatin resistance was
noted in recent studies, with Snail’s contribution largely evi-
denced. A study on A459 lung carcinoma cell lines (Wang
et al., 2014) showed increased Snail levels when treated with
cisplatin to develop resistance. Knockout of Snail using
siRNA led to a decrease in cell viability under cisplatin treat-
ment. In another study (Kaufhold and Bonavida, 2014), tran-
scriptome microarrays between ovarian tumour A2780 cells
and their cisplatin-resistant daughter A2780cis cells also
showed Snail overexpression. Again, use of SiRNA to knock-
out Snail transcripts resulted in EMT reversion and increased
cisplatin sensitivity. This reveals promising potential for
future methods of treatment of cisplatin-resistant tumours,
though further study, perhaps on live animals may be
required. Furthermore, siRNA is prone to mistakes (Latiﬁ
et al., 2011), so studies using more accurate methods of gen-
ome editing such as CRISPR/cas9 could be performed.
Interestingly, the study by Kaufhold and Bonavida (2014)
also revealed overexpression of Slug, Twist2 and Zeb2 in
cisplatin-resistant cells, whereas analysis of A459 lung carcin-
oma cell lines by Wang et al. (2014) did not demonstrate such
observations. A point of note in this study, however, is that
actual resistance of the cell after exposure to cisplatin seems to
have been assumed, not tested. Conclusions as to Snail, Slug
and Twist’s effect on these cells cannot therefore be fully asso-
ciated with its effect on cisplatin resistance. Furthermore, this
study used lung carcinoma cell lines, whereas Kaufhold and
Bonavida (Kaufhold and Bonavida, 2014) investigated ovarian
carcinoma lines. Thus, results from this are deemed more reli-
able. Nonetheless, both studies indicate a crucial role of Snail in
cisplatin resistance homologous in both ovarian and lung can-
cers. One study (Latiﬁ et al., 2011) on ovarian cancer cells
showed increased mRNA levels of Snail, Slug and Twist in
response to cisplatin. This may have been the tumour acquiring
resistance through transcription factor upregulation. This fur-
ther suggests the involvement of Slug and Twist in cisplatin
resistance. Further studies into Twist and Slug’s involvement
should be undergone by using CRISPR/cas9 to reduce their
expression and observe the effects. More physiological methods
of transcription factor repression could also be used, perhaps
by utilising an inhibitor such as oligonucleotide-Co(III) Schiff
base conjugate, which inhibits Snail, Slug and Sip1 (Harney
et al., 2009) by preventing binding to DNA. Other transcription
factors are not inhibited. This may therefore have potential for
development as a less error prone cancer therapeutic.
E-cadherin in normal ovarian
epithelium
Interestingly, E-cadherin presence in normal OSE is limited
compared to other epithelial tissues. Sundfeldt et al. (1997)
found E-cadherin expression was conﬁned to OSE in inclu-
sion cysts and deep clefts. Immunochemical staining revealed
no expression on the ovary surface. This is corroborated by
multiple studies investigating E-cadherin in OSE (Maines-
Bandiera and Auersperg, 1997). Maines-Bandiera and
Auersperg suggested that the mesenchymal-like morphology
of OSE cells allows rapid progression to EMT in monolayer
culture. However, investigation of metaplastic OSE cells by
Maines-Bandeira and Auersperg (1997) found an abundance
of E-cadherin expression. Furthermore, prominence of E-
cadherin increased in columnar and cuboidal OSE compared
to ﬂat. This suggests that, though absent in ﬂat OSE, E-
cadherin plays a role in speciﬁc intercellular adhesion in
cuboidal and columnar OSE, for instance, in epithelial inclu-
sion cysts. Furthermore, its expression in OSE may indicate
progression to metaplasia (Maines-Bandiera and Auersperg,
1997). Interestingly, morphology and E-cadherin expression
of metaplastic OSE resembles oviductal, endometrial and
endocervical epithelium (Auersperg et al., 1999). This may be
a result of OSE differentiation towards these related tissue
types during metaplastic progression. Indeed, transfection of
E-cadherin cDNA into mouse OSE resulted in initiation of a
metaplastic, epithelialized phenotype resembling neoplastic
OSE (Auersperg et al., 1999). This suggests that though E-
cadherin may act as a tumour suppressor in late stage carcin-
omas, its upregulation in OSE aids progression to metaplasia
and early neoplasia.
This ﬂuctuation in E-cadherin levels indicates a complex
and combinatorial regulation which is yet to be fully under-
stood. Although Snail Slug and Twist have been shown to
decrease E-cadherin expression in the transference from nor-
mal to malignant tissue, their presence in benign tumours
may not have the same effect. Indeed, though levels of these
TFs were signiﬁcantly higher in benign tumours (Yi et al.,
2014), E-cadherin expression was present in 40.4% more
benign tumour samples than normal or malignant tissue. This
prompts the consideration that yet another transcription fac-
tor or miRNA may inhibit Snail Slug and Twist in benign tis-
sue, thus negating subsequent E-cadherin down-regulation.
Identifying this factor might give an insight into the mechan-
isms of malignancy formation and targets for its reversal.
Furthermore, the increase of E-cadherin in benign tumours
suggests a direct upregulation via not only inhibition of Snail,
Slug and Twist, but another transcription factor. Should this
factor or mechanism of E-cadherin upregulation be identiﬁed,
its use in vivo to prevent EMT (and malignancy) might be
considered. Interestingly, in the same study, borderline ovar-
ian tumours showed a 50% presence of E-cadherin after west-
ern blotting (Yi et al., 2014). Though high, this level of
expression is 7% lower than in benign samples. This lower
expression may be a result of conversion from benign to
malignant phenotype. Thus, examination of transcription fac-
tor expression between benign and borderline ovarian
tumours would be a prudent area of study. Inspection of dif-
ferentially expressed genes in these tissues might identify fac-
tors responsible for benign to malignant transition. Such
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Review article Bioscience Horizons • Volume 11 2018
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
4
D
ow
nloaded from
 https://academ
ic.oup.com
/biohorizons/article-abstract/doi/10.1093/biohorizons/hzy010/5253900 by guest on 11 July 2019
factors would be promising targets for gene therapy. Though
E-cadherin plays a role in cancer progression, the speciﬁcs
remain unclear. Davidson (2001) suggested E-cadherin
expression occurs intermittently during expression. This idea
is supported by the differential E-cadherin expression depend-
ing on the stage of tumour (Yi et al., 2014). However, the rea-
soning for this discontinuous expression requires further
investigation. Until this ﬂuctuation can be fully explained,
manipulation of E-cadherin expression in cancer therapy may
not be a viable treatment. Understanding this complex expres-
sion is vital to determining both E-cadherin’s role in EMT
and its potential as a therapeutic target.
Conclusion
In conclusion, all three transcription factors reduce E-cadherin
expression and the mechanisms of this process are beginning to
be understood in more detail. Understanding this could allow
methods of knockdown of Snail, Slug and Twist in vivo to be
developed. Evidence that Snail and Slug work cooperatively
must be taken into account, as one might compensate for the
other’s loss. Twist, too, may play a role in this hierarchical
regulation. HIF1α has been found to be an upstream regulator
of Twist and perhaps Snail and Slug. It may be that post-
translational or transcriptional regulation is involved, and if
correct, this regulatory method could be augmented in vivo to
regulate Snail, Slug or Twist expression. Though interesting,
this requires far more research, as well as conﬁrmation of
HIF1α’s involvement. Its involvement would indicate hypoxic
conditions to be stimulator of metastasis. In addition, Snail has
been shown to correlate with cisplatin resistance. The involve-
ment of other transcription factors remains largely unknown
and requires more detailed research. Nonetheless, the discovery
of Snail’s connection could hold therapeutic values. If drugs
can be developed to remove or reduce Snail in patient tumours,
reversal of cisplatin resistance might be possible. It is also
plausible that reduction of other transcription factors as well as
Snail might aid to prevent EMT, which may prevent metastasis
of the primary tumour. Despite these promising discoveries, E-
cadherin regulation in ovarian carcinoma remains a complex
process. E-cadherin ﬂuctuation between normal, benign and
malignant tissue has yet to be explained. Though the role of
Twist, Snail and Slug in this intermittent expression is becom-
ing more deﬁned, much work is yet required before therapies
can be developed. Nonetheless, frequent investigation into this
process is beginning to ﬁll in the blanks. Once this picture is
complete, therapeutic treatment of ovarian cancer may become
far more plausible.
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